# Fetal Cell Analysis From Maternal Blood

> **NCT05671744** · NA · UNKNOWN · sponsor: **Menarini Biomarkers Singapore** · enrollment: 1500 (estimated)

## Conditions studied

- Prenatal Screening
- Pregnancy Related
- Genetic Disease

## Interventions

- **OTHER:** Cell-based non-invasive prenatal testing

## Key facts

- **NCT ID:** NCT05671744
- **Lead sponsor:** Menarini Biomarkers Singapore
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-22
- **Primary completion:** 2023-09
- **Final completion:** 2023-09
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05671744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05671744, "Fetal Cell Analysis From Maternal Blood". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05671744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*